BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Jin Y, Guo Y, Tan Z, Zhang X, Ye D, Yu Y, Peng S, Zheng L, Li J. Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid. Cancers (Basel) 2021;13:1179. [PMID: 33803322 DOI: 10.3390/cancers13051179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wang B, Xue Y, Zhai W. Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma. Front Immunol 2022;13:902060. [PMID: 35592336 DOI: 10.3389/fimmu.2022.902060] [Reference Citation Analysis]
2 Wang Z, Guo Y, Jin Y, Zhang X, Geng H, Xie G, Ye D, Yu Y, Liu D, Zhou D, Li B, Luo Y, Peng S, Li J. Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids. Cancer Cell Int 2021;21:519. [PMID: 34600546 DOI: 10.1186/s12935-021-02219-w] [Reference Citation Analysis]